Natera (NTRA) Non-Current Assets (2014 - 2026)
Natera's (NTRA) quarterly Non-Current Assets came in at $998.5 million in Q2 2026, up 206.8% on a YoY basis from $325.5 million in Q2 2025, and up 3.74% quarter-over-quarter from $962.6 million in Q1 2026.
Analysis
Natera (NTRA) Non-Current Assets (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Non-Current Assets for 13 consecutive years, with $998.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets rose 206.8% year-over-year to $998.5 million; the trailing twelve-month figure through Jun 2026 stood at $3.2 billion (up 170.91% YoY), and the FY2025 full-year result was $901.4 million, up 216.38% from the prior year.
- Non-Current Assets climbed to $998.5 million in Q2 2026 per NTRA's latest filing, from $962.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $998.5 million in Q2 2026 and bottomed at $164.4 million in Q1 2022.
- Historically, Non-Current Assets has averaged $348.9 million across 5 years, with a median of $211.0 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets slipped 0.13% in 2023, then surged 216.38% in 2025.
- Over 5 years, Non-Current Assets stood at $182.7 million in 2022, then grew by 0.27% to $183.2 million in 2023, then jumped by 55.56% to $284.9 million in 2024, then soared by 216.38% to $901.4 million in 2025, then increased by 10.78% to $998.5 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $998.5 million, $962.6 million, and $901.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 998.55 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 14.10 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 14.72 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 547.66 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 14.60 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 171.79 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 2.66 Bn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 78.32 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 220.12 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 337.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 998.55 Mn |
| Mar 31, 2026 | 962.59 Mn |
| Dec 31, 2025 | 901.41 Mn |
| Sep 30, 2025 | 374.16 Mn |
| Jun 30, 2025 | 325.47 Mn |
| Mar 31, 2025 | 315.98 Mn |
| Dec 31, 2024 | 284.92 Mn |
| Sep 30, 2024 | 268.38 Mn |
| Jun 30, 2024 | 215.17 Mn |
| Mar 31, 2024 | 206.76 Mn |
| Dec 31, 2023 | 183.15 Mn |
| Sep 30, 2023 | 179.24 Mn |
| Jun 30, 2023 | 182.38 Mn |
| Mar 31, 2023 | 189.41 Mn |
| Dec 31, 2022 | 182.66 Mn |
| Sep 30, 2022 | 179.48 Mn |
| Jun 30, 2022 | 165.42 Mn |
| Mar 31, 2022 | 164.44 Mn |
| Dec 31, 2021 | 143.35 Mn |
| Sep 30, 2021 | 120.15 Mn |